New Insights on Poststroke Epilepsy and Potential Biomarkers

Source: Frontiers in neurology

Summary

Researchers studied the relationship between certain molecules in the blood and the development of epilepsy after a stroke, known as poststroke epilepsy (PSE). They looked at 24 patients with PSE, 24 patients who had a stroke but did not develop epilepsy, and 24 patients with epilepsy unrelated to stroke. The team used advanced techniques to analyze blood samples and identify differences in specific molecules called microRNAs (miRNAs) and a protein known as brain-derived neurotrophic factor (BDNF).

The study found that a specific miRNA, called miR-10b-5p, was present in lower amounts in patients with PSE compared to those who only had a stroke. This suggests that miR-10b-5p could help identify patients at risk for developing epilepsy after a stroke. Although the researchers did not find significant differences in BDNF levels among the groups, they noted that BDNF levels were related to how long the patients had been experiencing seizures and how quickly they started having them, but only in the PSE group.

This research is important because it highlights a potential pathway that could help understand why some stroke patients develop epilepsy while others do not. However, the study has limitations, such as the timing of blood sample collection, which was done after the stroke rather than immediately after. More research is needed to see if these findings can be used to predict PSE early on and improve treatment options for patients at risk.

Original source